SBIR PHASE I ANTIBODY ARRAY FOR CANCER DETECTION (TOPIC236)

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$150,000.00
Award Year:
2008
Program:
SBIR
Phase:
Phase I
Contract:
N43CN0800020
Agency Tracking Number:
N43CN0800020
Solicitation Year:
n/a
Solicitation Topic Code:
n/a
Solicitation Number:
n/a
Small Business Information
PHARMASEQ, INC.
PHARMASEQ, INC., 11 DEER PARK DR, STE 104, MONMOUTH JUNCTION, NJ, 08852
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
027661870
Principal Investigator:
WLODEK MANDECKI
(732) 355-0100
mandecki@pharmaseq.com
Business Contact:
() -
mandecki@pharmaseq.com
Research Institution:
n/a
Abstract

This Phase I project aims to develop a technology to simultaneously measure three biomarkders for early prostate cancer detection using an electronic radio frequency (RF) light-powered microtransponder. Antigens will be captured using antibodies coupled to the microtransponders and detected using biotinylated antibodies.

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government